Other News

On 21 November 2018, the European Brain Council, together with its industry partners, hosts the event “Enhanced engagement through public-private partnerships: Sustaining therapeutic innovation to address patient needs” as part of its Value of Innovation series.

Our 2018 General Assembly will take place on November 21, in Brussels, the agenda is currently in development.       The statutory General Assembly will take place during the morning session and we will propose the mission adaptation of… Continue Reading

More than one in three people will eventually suffer from brain disease, yet only 10% of scientific resources are devoted to their research. Private initiatives such as Run4Brain are crucial in not only raising awareness but also raising funds that… Continue Reading

Prof. F. Fazekas, President of the EAN and Prof. Z. Katsarava President of the European Headache Federation (EHF) are pleased to announce that: EAN has joined with EHF to promote optimal management of headache disorders care in Europe. EAN and… Continue Reading

The European Brain Council (EBC) recently provided feedback to the European Commission on the Horizon Europe proposals that were published in June 2018.

WHEN: November 19 – 21, 2018
WHERE: Brussels, Begium
WHO: Anyone between the ages of 18 and 35, living in Europe, who is affected by a neurological disorder
The workshop will take place through the English language. A good level… Continue Reading

  The XXIII World Congress of the International Association of Parkinson’s Disease and Related Disorders (IAPRD) was held from August 19th to 22th, 2018, in Lyon, France, at the Lyon Convention Centre, a beautiful location designed by the famous Italian… Continue Reading

          by Anna Sauerbier         European Brain Council provides feedback on the Horizon Europe proposals http://www.braincouncil.eu/activities/news/ebc-provides-feedback-on-the-horizon-europe-proposals/   The FDA designates device aiming to mitigate symptoms of agitation and depression associated with AD as… Continue Reading

The BioMed Alliance through the work of its Task Force “Clinical Trials” published a statement on the need for Europe to implement patient-centered clinical research.     Precision medicine approaches the treatment of disease via an individual’s genes, environment, and… Continue Reading

            by Anna Sauerbier         EFNA’s Survey of Young Europeans with Neurological Conditions https://www.efna.net/wp-content/uploads/2018/07/EFNAYoungPeopleSurvey.pdf   Two years after Brexit vote, a cloud still hangs over research https://sciencebusiness.net/news/two-years-after-brexit-vote-cloud-still-hangs-over-research   Societal Impact of Pain… Continue Reading

Biomed Alliance: Prof. Axel Pries, President of the Biomed Alliance, meets with MEP Christian Ehler, rapporteur to the EP for the EC Horizon Europe Framework.   In view of the ongoing political discussions around the European Commission’s proposal for funding… Continue Reading

                                                 Thanks to a memorandum of understanding between the European academy of neurology (EAN) and the African academy of neurology (AFAN), for the second year, AFAN has had an exhibition stand at the EAN congress; this year in Lisbon, Portugal.… Continue Reading

Last week marked the launch of the EBC statement “Counting down to zero: Towards a future with underfunded health research?”, which calls on the European Commission, the European Parliament and the Council of the European Union to increase the budget of the 9th Framework Programme of Research & Innovation, or “Horizon Europe”, to at least €120 billion.

Prof. F. Fazekas, President of the EAN and Prof. W. Struhal President of EFAS are pleased to announce that: EAN has joined with EFAS to promote Autonomic Nervous System (ANS) disorders in Europe and advance optimal care and management for… Continue Reading

EFNA member association Dystonia Europe was among the winners of the Brain, Mind, and Pain Patient-Centred Innovation Grant, announced on Wednesday in Brussels.